Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan

被引：37
|
作者：
Yokota, Shumpei [1 ]
Imagawa, Tomoyuki [1 ]
Mori, Masaaki [2 ]
Miyamae, Takako [1 ]
Takei, Syuji [3 ]
Iwata, Naomi [4 ]
Umebayashi, Hiroaki [5 ]
Murata, Takuji [6 ]
Miyoshi, Mari [7 ]
Tomiita, Minako [8 ]
Nishimoto, Norihiro [9 ]
Kishimoto, Tadamitsu [10 ]
机构：
[1] Yokohama City Univ, Sch Med, Dept Paediat, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Med Ctr, Dept Paediat, Yokohama, Kanagawa 2360004, Japan
[3] Kagoshima Univ, Sch Hlth Sci, Kagoshima 890, Japan
[4] Aichi Childrens Hlth & Med Ctr, Aichi, Japan
[5] Miyagi Childrens Hosp, Sendai, Miyagi, Japan
[6] Osaka Med Coll, Dept Paediat, Osaka, Japan
[7] Kobe Childrens Hosp, Kobe, Hyogo, Japan
[8] Chiba Univ, Grad Sch Med, Dept Paediat, Chiba, Japan
[9] Wakayama Med Univ, Lab Immune Regulat, Osaka, Japan
[10] Osaka Univ, Immunol Frontier Res Ctr, Osaka, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷 / 04期
关键词：
RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; SAFETY; ETANERCEPT; CATEGORIES; DISEASE; TRIAL;
D O I：
10.1136/annrheumdis-2012-202310
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：627 / 628
页数：2
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study
    Chatham, W. Winn
    Furie, Richard
    Saxena, Amit
    Brohawn, Philip
    Schwetje, Erik
    Abreu, Gabriel
    Tummala, Raj
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 837 - 847
  • [32] Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis
    Brunner, Hermine, I
    Ruperto, Nicolino
    Ramanan, Athimalaipet, V
    Horneff, Gerd
    Minden, Kirsten
    Penades, Inmaculada Calvo
    Alexeeva, Ekaterina
    Cleary, Gavin
    Stern, Sara M.
    Kone-Paut, Isabelle
    Velazquez, Maria del Rocio Maldonado
    Rabinovich, C. Egla
    Remesal, Agustin
    Silva, Clovis Artur
    Nikishina, Irina
    Zucchetto, Mauro
    Brockwell, Laura
    Gordon, Oliver
    Nagel, Sandra
    De Benedetti, Fabrizio
    [J]. RHEUMATOLOGY, 2024,
  • [33] Long-term safety and efficacy of zafirlukast in the treatment of asthma: interim results of an open-label extension trial
    Grossman, J
    Smith, LJ
    Wilson, AM
    Thyrum, PT
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (04) : 361 - 369
  • [34] LONG-TERM SPARSENTAN TREATMENT IN FSGS IN THE DUET OPEN-LABEL EXTENSION (OLE)
    Trachtman, Howard
    Srivastava, Tarak
    Tesar, Vladimir
    Campbell, Kirk N.
    Rheault, Michelle N.
    Komers, Radko
    Murphy, Edward
    Prasad, Andy
    Gesualdo, Loreto
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S99 - S99
  • [35] Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
    Raghu, Ganesh
    van den Blink, Bernt
    Hamblin, Mark J.
    Brown, A. Whitney
    Golden, Jeffrey A.
    Ho, Lawrence A.
    Wijsenbeek, Marlies S.
    Vasakova, Martina
    Pesci, Alberto
    Antin-Ozerkis, Danielle E.
    Meyer, Keith C.
    Kreuter, Michael
    Moran, Donna
    Santin-Janin, Hugues
    Aubin, Francois
    Mulder, Geert-Jan
    Gupta, Renu
    Richeldi, Luca
    [J]. LANCET RESPIRATORY MEDICINE, 2019, 7 (08): : 657 - 664
  • [36] LONG-TERM TREATMENT OF PARTIAL EPILEPSY WITH ESLICARBAZEPINE ACETATE: RESULTS OF A 1-YEAR OPEN-LABEL EXTENSION STUDY
    Guekht, A.
    Elger, C.
    Halasz, P.
    Maia, J.
    Almeida, L.
    Soares-da-Silva, P.
    [J]. EPILEPSIA, 2009, 50 : 106 - 106
  • [37] Long-Term Treatment With Deutetrabenazine Is Associated With Continued Improvement in Tardive Dyskinesia: Results From an Open-Label Extension Study
    Hauser, R.
    Barkay, H.
    Fernandez, H.
    Factor, S.
    Jimenez-Shahed, J.
    Gross, N.
    Gordon, M.
    Savola, J. M.
    Anderson, K.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S596 - S596
  • [38] PERSISTENCE OF TOFACITINIB IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN OPEN-LABEL, LONG-TERM EXTENSION STUDIES UP TO 7 YEARS
    Pope, J.
    Keystone, E.
    Jamal, S.
    Wang, L.
    Fallon, L.
    Woolcott, J.
    Lazariciu, I.
    Haraoui, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 245 - 245
  • [39] Safety and efficacy of tofacitinib for up to 9.5years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
    Wollenhaupt, Juergen
    Lee, Eun-Bong
    Curtis, Jeffrey R.
    Silverfield, Joel
    Terry, Ketti
    Soma, Koshika
    Mojcik, Chris
    DeMasi, Ryan
    Strengholt, Sander
    Kwok, Kenneth
    Lazariciu, Irina
    Wang, Lisy
    Cohen, Stanley
    [J]. ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [40] Persistence of Tofacitinib in the Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up to 9.5 Years
    Pope, Janet E.
    Keystone, Edward
    Jamal, Shahin
    Wang, Lisy
    Fallon, Lara
    Woolcott, John
    Lazariciu, Irina
    Chapman, Douglass
    Haraoui, Boulos
    [J]. ACR OPEN RHEUMATOLOGY, 2019, 1 (02) : 73 - 82
12345